Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Aprea Therapeutics, Inc. (APRE)

NASDAQ

$0.80

$+0.00

(+0.13%)

Regular Market

Aprea Therapeutics, Inc. (APRE) Live Price Chart

Last updated: ⁦2026-09-04 14:25:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Aprea Therapeutics, Inc. (APRE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.80, with a market capitalisation of $10.32M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.55 to $1.69. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$10.32M
Open	$0.80
Day's High	$1,062.20
Day's Low	$0.55
Previous Close	$0.81
Volume	29.21K
Average Volume	--
P/E Ratio	--
52-Week High	$1.69
52-Week Low	$0.55
Dividend Yield	--
Earnings Date	--

Aprea Therapeutics, Inc. (APRE) Stock Price Today

Aprea Therapeutics, Inc. (APRE) is currently trading at $0.80 as of 2026-09-04 14:23:00, down 0.66% ($0.01) from the previous close of $0.81

During today's regular trading session, APRE has traded between $0.55 and $1,062.20, with a trading volume of 29.21K shares. The current price is near the lower end of today's range.

Aprea Therapeutics, Inc. (APRE) 7-Day Stock Price Change

Over the past seven days, Aprea Therapeutics, Inc. (APRE) moved from $0.85 to $0.80, representing a decline of 5.25% ($0.04).

The stock traded between $0.80 and $0.80 during the period. The latest price is near the upper end of the 7-day range, indicating strong downward.

The average daily volume was 398.05 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

APRE 52-Week Price Position

Position in Range: 22.2%

52W Low$0.55

52W High$1.69

APRE is currently trading at $0.80, placing it 22.2% of the way from its 52-week low of $0.55 to its 52-week high of $1.69. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Aprea Therapeutics, Inc. (APRE)?

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

Aprea Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	8
Exchange	NASDAQ
Company Website	https://www.aprea.com

How to Buy Aprea Therapeutics, Inc. (APRE) Stock on MEXC

Eligible investors can buy real shares of Aprea Therapeutics, Inc. (APRE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for APRE and Place Your Order

Open the RealStocks trading page and search for APRE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Aprea Therapeutics, Inc. (APRE) stock price today?

Aprea Therapeutics, Inc. (APRE) is currently trading at $ 0.80, down 0.66% ($0.01) from the previous close of $ 0.81. Intraday prices update in real time during regular trading hours.

2.Is APRE stock going up or down today?

As of 2026-09-04 14:23:00, APRE is trading at $ 0.80, down 0.66% ($0.01) from its previous close of $ 0.81. The stock has traded between $ 0.55 and $ 1,062.20 during today’s regular session. Past price movements do not guarantee future results.

3.What is APRE pre-market price?

As of 2026-09-04 14:23:00, APRE is trading at $ 0.80 in pre-market trading, down 1.40% ($0.01) from the previous close of $ 0.81. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is APRE after-hours price?

As of 2026-09-04 14:23:00, APRE is trading at -- in after-hours trading, -- from the regular-session close of $ 0.81. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is APRE stock trading now?

APRE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does APRE sit relative to its 52-week high and low?

Over the past 52 weeks, APRE has traded between a low of $ 0.55 and a high of $ 1.69. At $ 0.80, the stock is positioned 22.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Aprea Therapeutics, Inc. in?

Aprea Therapeutics, Inc. (APRE) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Aprea Therapeutics, Inc.'s market capitalisation and where is it listed?

Aprea Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 10.32M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is APRE valued in terms of P/E ratio and EPS?

APRE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.98. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Aprea Therapeutics, Inc. pay a dividend?

Aprea Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.